Adenosine 6mg/2ml solution for injection vials

Ország: Egyesült Királyság

Nyelv: angol

Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktív összetevők:

Adenosine

Beszerezhető a:

Wockhardt UK Ltd

ATC-kód:

C01EB10

INN (nemzetközi neve):

Adenosine

Adagolás:

3mg/1ml

Gyógyszerészeti forma:

Solution for injection

Az alkalmazás módja:

Intravenous

Osztály:

No Controlled Drug Status

Recept típusa:

Valid as a prescribable product

Termék összefoglaló:

BNF: 02030200; GTIN: 5012727907376

Termékjellemzők

OBJECT 1
ADENOSINE 3MG/ML SOLUTION FOR INJECTION
Summary of Product Characteristics Updated 15-Jun-2015 | Wockhardt UK
Ltd
1. Name of the medicinal product
Adenosine 3mg/ml Solution for Injection
2. Qualitative and quantitative composition
Each vial contains 6mg of adenosine per 2ml (3mg/ml).
Contains sodium.
For a full list of excipients, see Section 6.1.
3. Pharmaceutical form
Solution for injection (injection).
A clear, colourless solution free from visible particles.
4. Clinical particulars
4.1 Therapeutic indications
Rapid conversion to a normal sinus rhythm of paroxysmal
supraventricular tachycardias, including those
associated with accessory by-pass tracts (Wolff-Parkinson-White
Syndrome).
_Paediatric population_
Rapid conversion to a normal sinus rhythm of paroxysmal
supraventricular tachycardia in children aged 0
to 18 years.
DIAGNOSTIC INDICATIONS
Aid to diagnosis of broad or narrow complex supraventricular
tachycardias. Although adenosine injection
will not convert atrial flutter, atrial fibrillation or ventricular
tachycardia to sinus rhythm, the slowing of
AV conduction helps diagnosis of atrial activity.
Sensitisation of intra-cavitary electrophysiological investigations.
4.2 Posology and method of administration
METHOD OF ADMINISTRATION
Adenosine should be administered by rapid intravenous (IV) bolus
injection into a vein or into an IV line.
If given into an IV line it should be injected through as proximally
as possible, and followed by a rapid
saline flush. If administered through a peripheral vein, a large bore
cannula should be used.
During administration of adenosine cardio-respiratory resuscitation
equipment must be available for
immediate use if necessary.
Adenosine is intended for use with continuous monitoring and ECG
recording during administration.
Patients who develop high-level AV block at a particular dose should
not be given further dosage
increments.
POSOLOGY
ADULTS:
Initial dose: 3mg given as a rapid intravenous bolus (over 2 seconds).
Second dose: If the first dose does not result